Indication

Persistent pulmonary hypertension of the newborn

Persistent pulmonary hypertension of the newborn is a life-threatening cardiopulmonary condition occurring in neonates—predominantly term and near-term infants—characterized by a failure of the normal circulatory transition at birth. Read more about Persistent pulmonary hypertension of the newborn

0 drugs 0 manufacturers

Advertisement

Drugs that treat it

Common Persistent pulmonary hypertension of the newborn therapies.

0 drugs

No drugs are available

This indication does not currently contain public drugs.

Filter & compare in the drug finder →Opens the drug finder with Persistent pulmonary hypertension of the newborn preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Persistent pulmonary hypertension of the newborn.

Persistent pulmonary hypertension of the newborn is a life-threatening cardiopulmonary condition occurring in neonates—predominantly term and near-term infants—characterized by a failure of the normal circulatory transition at birth.

It is defined by sustained elevation of pulmonary vascular resistance, which restricts pulmonary blood flow and causes extrapulmonary right-to-left shunting of deoxygenated blood through the patent ductus arteriosus and foramen ovale.

This persistent elevation results in severe, refractory hypoxemia and respiratory distress shortly after delivery, frequently occurring idiopathically or secondary to meconium aspiration syndrome, respiratory distress syndrome, pneumonia, or pulmonary hypoplasia.

Personalize your experience

Follow Persistent pulmonary hypertension of the newborn and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it